Midwest Trust Co Invests $668,000 in Cabot Corporation $CBT

Midwest Trust Co bought a new stake in Cabot Corporation (NYSE:CBT) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 8,908 shares of the specialty chemicals company’s stock, valued at approximately $668,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. LSV Asset Management boosted its position in Cabot by 318.0% in the 1st quarter. LSV Asset Management now owns 571,034 shares of the specialty chemicals company’s stock valued at $47,476,000 after buying an additional 434,434 shares during the last quarter. American Century Companies Inc. boosted its holdings in Cabot by 13.2% in the first quarter. American Century Companies Inc. now owns 1,498,268 shares of the specialty chemicals company’s stock valued at $124,566,000 after purchasing an additional 174,921 shares during the last quarter. AQR Capital Management LLC boosted its holdings in Cabot by 79.5% in the first quarter. AQR Capital Management LLC now owns 389,244 shares of the specialty chemicals company’s stock valued at $31,626,000 after purchasing an additional 172,410 shares during the last quarter. Nuveen LLC purchased a new stake in Cabot during the 1st quarter worth approximately $12,365,000. Finally, Caisse DE Depot ET Placement DU Quebec raised its position in shares of Cabot by 279.2% in the 1st quarter. Caisse DE Depot ET Placement DU Quebec now owns 160,628 shares of the specialty chemicals company’s stock valued at $13,355,000 after purchasing an additional 118,266 shares in the last quarter. Hedge funds and other institutional investors own 93.18% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on CBT. Weiss Ratings reissued a “hold (c)” rating on shares of Cabot in a research report on Wednesday, October 8th. Zacks Research lowered shares of Cabot from a “hold” rating to a “strong sell” rating in a report on Friday, November 7th. UBS Group cut their target price on shares of Cabot from $82.00 to $65.00 and set a “neutral” rating on the stock in a research note on Wednesday, November 5th. Finally, Mizuho decreased their price target on Cabot from $90.00 to $88.00 and set an “outperform” rating for the company in a research note on Friday, October 3rd. One research analyst has rated the stock with a Buy rating, two have given a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Reduce” and an average price target of $79.33.

Insiders Place Their Bets

In other Cabot news, CEO Sean D. Keohane sold 114,436 shares of the business’s stock in a transaction on Thursday, August 14th. The stock was sold at an average price of $79.28, for a total transaction of $9,072,486.08. Following the completion of the transaction, the chief executive officer owned 361,518 shares in the company, valued at approximately $28,661,147.04. The trade was a 24.04% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 3.03% of the stock is owned by insiders.

Cabot Price Performance

CBT opened at $61.39 on Wednesday. The company has a quick ratio of 1.41, a current ratio of 2.13 and a debt-to-equity ratio of 0.66. The company’s 50-day moving average price is $72.65 and its 200 day moving average price is $75.25. Cabot Corporation has a fifty-two week low of $58.99 and a fifty-two week high of $116.74. The firm has a market cap of $3.27 billion, a price-to-earnings ratio of 8.02 and a beta of 0.90.

Cabot (NYSE:CBT) last posted its earnings results on Monday, November 3rd. The specialty chemicals company reported $1.70 EPS for the quarter, missing the consensus estimate of $1.72 by ($0.02). The company had revenue of $899.00 million for the quarter, compared to the consensus estimate of $967.02 million. Cabot had a net margin of 11.14% and a return on equity of 25.68%. The firm’s revenue for the quarter was down 10.2% compared to the same quarter last year. During the same period last year, the company posted $1.80 earnings per share. Cabot has set its FY 2026 guidance at 6.000-7.00 EPS. As a group, sell-side analysts expect that Cabot Corporation will post 7.57 earnings per share for the current year.

About Cabot

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.